Beryl Drugs Fair Value
Beryl Drugs (BERLDRG) average fair value is ₹72.29 across 3 valuation models — P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, vs a current market price of ₹20.44 (+253.69%), fair value range ₹20.0–₹144.78. See BERLDRG P/B ratio history to compare market price against book value per share.
Fair Value Analysis Export
BERLDRG Fair Value vs Current Price — Valuation Summary
BERLDRG average fair value, fair value range, price gap and valuation status across 3 models: P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation. Also explore BERLDRG share price charts to track price trends across different timeframes.
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
BERLDRG Fair Value Analysis — Data Sources & Coverage
Beryl Drugs financial data sources, valuation methods applied and sector benchmarks used. For live price and a broader fundamental view, visit BERLDRG share price.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
BERLDRG vs Healthcare Sector Peers — P/E, P/B & Market Cap
Beryl Drugs P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | 0.2 | ₹41 |
| Accretion Pharmaceuticals | ACCPL | 17.91 | 2.7 | ₹120 |
| Jeena Sikho Lifecare | JSLL | 40.38 | 23.07 | ₹7,944 |
| Par Drugs & Chemical | PAR | 8.2 | 0.96 | ₹103 |
| Aurobindo Pharma | AUROPHARMA | 25.16 | 2.5 | ₹87,806 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.